Related Articles
Tumor necrosis factor receptor 2 may promote the proliferation and drug resistance of Kapras299 and L428 lymphoma cells via the AKT and WNT/β‑catenin signaling pathways
TNFR2 promotes Adriamycin resistance in breast cancer cells by repairing DNA damage
Clinical implications of tumor necrosis factor receptor 2 in breast cancer
Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways
Inhibitory effect of carbonyl reductase 1 on ovarian cancer growth via tumor necrosis factor receptor signaling